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The greatest difficulties with UV-Vis multi determination methods arise when the
analytes to be determined give partly or fully overlapped spectra. Multivariate calibra-
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In the present work, three different spectrophotometric
methods for simultaneous estimation of ramipril, aspirin
and atorvastatin calcium in raw materials and in formu-
lations are described. Overlapped data was quantitative-
ly resolved by using chemometric methods, viz. inverse
least squares (ILS), principal component regression (PCR)
and partial least squares (PLS). Calibrations were constru-
cted using the absorption data matrix corresponding to
the concentration data matrix. The linearity range was
found to be 1–5, 10–50 and 2–10 µg mL–1 for ramipril, as-
pirin and atorvastatin calcium, respectively. The absorb-
ance matrix was obtained by measuring the zero-order
absorbance in the wavelength range between 210 and
320 nm. A training set design of the concentration data
corresponding to the ramipril, aspirin and atorvastatin
calcium mixtures was organized statistically to maximize
the information content from the spectra and to minimize
the error of multivariate calibrations. By applying the re-
spective algorithms for PLS 1, PCR and ILS to the measur-
ed spectra of the calibration set, a suitable model was ob-
tained. This model was selected on the basis of RMSECV
and RMSEP values. The same was applied to the predic-
tion set and capsule formulation. Mean recoveries of the
commercial formulation set together with the figures of
merit (calibration sensitivity, selectivity, limit of detection,
limit of quantification and analytical sensitivity) were es-
timated. Validity of the proposed approaches was succe-
ssfully assessed for analyses of drugs in the various pre-
pared physical mixtures and formulations.
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tion is a useful tool in the analysis of multicomponent mixtures because it allows rapid
and simultaneous determination of each component in the mixture with reasonable ac-
curacy and precision and without the need of lengthy separation procedures. With the
aid of modern instrumentation to acquire and digitize spectral information and power-
ful computers to process large amounts of data, chemometric methods such as classical
least squares (CLS), inverse least squares (ILS), principle component regression (PCR)
and partial least squares (PLS) regression are finding increasing use in quantitative analy-
sis of complex mixtures, offering an interesting alternative to chromatographic techni-
ques.
Atorvastatin (AT), (3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-(pro-
pan-2-yl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid, is a synthetic lipid-lowering agent
(1). AT is an inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A reductase. Ramipril (RA),
(2S,3aS,6aS)-1-[(2S)-2-[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]aminopropanoyl]-octa-
hydrocyclopenta[b]pyrrole-2-carboxylic acid, is an angiotensin converting enzyme inhibi-
tor, used to treat hypertension and congestive heart failure (2). Acetylsalicylic acid (AS)
is 2-acetyloxybenzoic acid, often used as an analgesic, antipyretic, anti-inflammatory and
antiplatelet agent (3).
Literature survey revealed several analytical methods reported for the determina-
tion of AS, AT and RA (4–11) in pharmaceutical dosage forms and biological samples.
No method is reported for simultaneous estimation of AT, RA and AS in combined for-
mulations applying chemometrics. Hence, the aim was to develop a selective, sensitive
and accurate method for estimating the three components simultaneously.
In recent years, multivariate calibration techniques, such as CLS, ILS, PCR and PLS,
started to be applied to the analysis of analytical data obtained in all instrumentations
(12). The main advantages of these techniques are the following: higher speed of pro-
cessing data concerning the values of concentrations and absorbances of compounds
with strongly overlapping spectra, errors of the calibration model are minimized by
measuring the absorbance values at many points in the wavelength range of zero-order
spectra. In this work, laboratory mixtures and capsules containing RA, AS and AT were
investigated and resolved by three chemometric methods using zero-order spectra.
EXPERIMENTAL
Instruments
A double-beam Shimadzu (Japan) UV-vis spectrophotometer, model UV-2550 PC
equipped with 1-cm quartz cells, was used. The bundled software used was UVPC
»WINLAB« software version 3.1 (Shimadzu). ILS, PCR and PLS-1 analyses were carried
out by using the PLS-Toolbox software version 5.0 (demo) for use with MATLAB 7.0.
Solvent, stock and standard solutions and pharmaceutical formulations
Methanol was used as the solvent for all the solution preparations, since it was found
to be the common solvent for all the three drugs. To prepare stock solutions, 100.0 mg of
284
A. S. K. Sankar et al.: Simultaneous estimation of ramipril, acetylsalicylic acid and atorvastatin calcium by chemometrics assisted
UV-spectrophotometric method in capsules, Acta Pharm. 61 (2011) 283–296.
all the three drugs were weighed separately into a 100-mL standard volumetric flask,
dissolved in a few mL of methanol and finally made up to the volume with the same
solvent.
Standard solutions. – Calibration and validation (prediction) set. – A training set of 25
standard mixture solutions containing 1–5, 10–50 and 2–10 µg mL–1 of RA, AS and AT,
respectively, was made daily from stock solutions using methanol as diluent. Also, a vali-
dation set of 16 synthetic mixtures containing various concentrations in the range of 1.2–4.8,
12.0–48.0 and 2.5–10.0 µg mL–1 of RA, AS and AT, respectively, was prepared from the
same stock solutions to verify the model capability of predicting the synthetic laboratory
mixture. Concentration ranges of the calibration and prediction sets are shown in Tables
I and II.
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Result found (µg mL–1)
PLS 1 PCR ILS
RA AS AT RA AS AT RA AS AT RA AS AT
1 3 30 6 2.92 29.52 5.81 2.92 30.10 5.81 3.00 29.77 5.93
2 3 10 2 3.04 9.97 2.05 3.04 10.14 2.05 2.95 10.35 1.95
3 1 10 10 0.99 9.69 9.84 0.99 9.73 9.84 0.99 9.36 9.93
4 1 50 4 1.01 48.76 3.80 1.01 49.70 3.80 1.02 49.61 4.16
5 5 20 10 4.89 20.09 10.00 4.89 20.20 10.00 4.97 20.65 9.76
6 2 50 6 2.05 50.53 6.35 2.05 50.20 6.35 1.95 50.29 5.96
7 5 30 4 5.03 30.88 4.05 5.03 29.90 4.05 4.96 29.78 4.15
8 3 20 4 2.98 20.12 4.09 2.98 19.88 4.09 2.95 19.89 4.02
9 2 20 8 1.98 20.08 7.92 1.98 19.78 7.92 1.94 19.94 8.09
10 2 40 10 2.03 39.90 9.75 2.03 40.02 9.75 2.00 40.30 9.96
11 4 50 8 3.92 51.03 7.77 3.92 50.37 7.77 3.98 50.40 7.93
12 5 40 6 5.09 39.91 5.99 5.09 39.92 5.99 5.02 40.47 5.82
13 4 30 10 3.98 30.22 9.91 3.98 30.02 9.91 4.03 29.95 9.89
14 3 50 10 3.04 49.56 10.58 3.04 49.91 10.58 3.08 49.96 10.35
15 5 50 2 4.97 49.70 1.90 4.97 49.80 1.90 4.99 49.67 1.93
16 5 10 8 5.04 10.43 8.07 5.04 9.80 8.07 5.02 9.96 7.93
17 1 40 2 0.97 40.41 2.05 0.97 40.10 2.05 1.05 40.12 1.82
18 4 10 6 4.08 10.18 6.08 4.08 9.99 6.08 4.02 9.96 5.89
19 1 30 8 1.04 29.46 7.93 1.04 29.95 7.93 0.91 30.31 7.92
20 3 40 8 2.99 40.56 7.75 2.99 40.11 7.75 3.01 40.12 8.05
21 4 40 4 4.03 39.58 3.95 4.03 39.89 3.95 4.02 40.07 3.96
22 4 20 2 3.96 20.12 2.04 3.96 20.04 2.04 3.96 20.00 2.01
23 2 10 4 1.99 9.68 3.93 1.99 10.38 3.93 1.98 10.70 4.06
24 1 20 6 1.02 19.32 6.31 1.02 20.12 6.31 0.94 19.74 6.09
25 2 30 2 1.97 30.12 2.07 1.97 29.93 2.07 2.00 29.92 2.00
RA – ramipril, AS – acetylsalicylic acid, AT – atorvastatin calcium
Pharmaceutical capsule formulation. – Capsule formulation, Polytorva (containing 5 mg
ramipril (RA), 75 mg acetylsalicylic acid (AS) and 10 mg atorvastatin calcium (AT) along
with excipients) was analyzed by the proposed chemometric methods.
Methods
Design of experiments. – This study employs a multilevel partial factorial design for
five concentration levels (level (l) = 5). Mutually orthogonal designs are only possible if
the number of concentration levels is a prime number or a power of a prime number.
The design requires at least l2 experiments (25 experiments) to study a mixture. After
numbering the levels from –2 (lowest) to +2 (highest), the complete design was obtain-
ed, using what is often described as a cyclic generator or permuter (–2, –1, 2, 1, –2), a re-
peater of 0 (middle level) and a difference vector (0 2 3 1). In this type of design, there is
no correlation between any concentrations of the compounds between two columns, i.e.,
the columns are orthogonal in nature; hence, the correlation coefficient is zero.
Inverse least squares (ILS) method. – The inverse expression of the Bouguer-Beer-Lam-
bert law in UV/Vis spectroscopy when applied to multiple linear regression leads to the
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Result found (mg mL–1)
PLS 1 PCR ILS
RA AS AT RA AS AT RA AS AT RA AS AT
1 1.2 12 2.5 1.17 11.81 2.42 1.17 12.05 2.42 1.20 11.91 2.47
2 1.2 24 5.0 1.21 23.94 5.13 1.22 24.36 5.14 1.18 24.84 4.87
3 2.4 24 10.0 2.36 23.27 9.84 2.37 23.38 9.85 2.38 22.46 9.93
4 2.4 48 5.0 2.43 46.81 4.75 2.44 47.76 4.75 2.44 47.63 5.20
5 4.8 24 2.5 4.69 24.11 2.50 4.70 24.27 2.50 4.77 24.77 2.44
6 2.4 12 7.5 2.46 12.13 7.93 2.46 12.06 7.94 2.34 12.07 7.45
7 1.2 36 7.5 1.21 37.06 7.60 1.21 35.92 7.61 1.19 35.74 7.78
8 3.6 36 5.0 3.58 36.22 5.11 3.58 35.83 5.12 3.54 35.80 5.02
9 3.6 24 7.5 3.56 24.10 7.43 3.57 23.76 7.43 3.49 23.92 7.59
10 2.4 36 2.5 2.44 35.91 2.44 2.44 36.06 2.44 2.40 36.27 2.49
11 3.6 12 10.0 3.53 12.25 9.72 3.53 12.10 9.73 3.58 12.10 9.91
12 1.2 48 10.0 1.22 47.90 9.98 1.22 47.95 9.99 1.20 48.56 9.70
13 4.8 48 7.5 4.78 48.36 7.43 4.78 48.07 7.44 4.84 47.91 7.42
14 4.8 36 10.0 4.86 35.68 10.58 4.86 35.97 10.59 4.93 35.97 10.35
15 3.6 48 2.5 3.58 47.71 2.38 3.58 47.86 2.38 3.59 47.68 2.41
16 4.8 12 5.0 4.84 12.52 5.04 4.84 11.77 5.05 4.82 11.95 4.96
RA – ramipril, AS – acetylsalicylic acid, AT – atorvastatin calcium
ILS method. Mathematical formulations of this method, in the matrix compact form, can
be written (14) as follows:
C = P ´ A (1)
where C is concentration matrix, P is calibration coefficient and A is the absorbance data
matrix. Coefficient P can be determined as follows:
P = (AT A)–1 ATC (2)
Instead of finding the transpose and inverse for the large data set, the Moore-
-Penrose pseudo inverse (a function in the MATLAB 7.0 ver.) of the absorbance data ma-
trix was found out (a calculation method to find out the inverse of a large data matrix).
The prediction of unknown spectra (aT) can be made with the following equation:
C0 = aT ´ P (3)
C0 and aT is the unknown sample concentration. Superscript T on all the letters refers to
the transpose of a matrix.
Principal component regression (PCR) method. – In the spectral work, the following steps
can explain the fundamental concept of PCR: (i) The original data obtained in absorbances
(A) is smoothed by using the Savitzky–Golay smoothing method (a function in the
MATLAB 7.0 ver.) and concentration (C) of the analyte is reprocessed by mean-centering
as A0 and C0, respectively. ii) The covariance dispersion matrix of the centered matrix A0 is
computed. The normalized eigenvalues and eigenvectors are calculated starting from the
square covariance matrix. The number of optimal principal components (eigenvectors) is
selected by considering only the highest values of the eigenvalues. The other eigenvalues
and their corresponding eigenvectors were eliminated from this study. Using the ordinary
linear regression (12–14):
C = a + b ´ A (4)
Coefficients a and b are calculated. To reach this objective coefficient b is to be estimated
first as:
b = P ´ q (5)
where P is the matrix of eigenvectors and q is the C-loading given by
q = D ´ TT ´ A (6)
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Here, TT is the transpose of the score matrix T, D is a diagonal matrix having on the
components of the selected eigenvalues. Knowing b, we can easily find a by using the
formula:
a = Cmean – ATmean ´ b (7)
where ATmean represents the transpose of the matrix having the mean absorbance values
and Cmean is the mean concentration of the calibration set.
Partial least squares (PLS) method. – The PLS calibration using the orthogonalized PLS
algorithm developed by Wold (12–14) and extensively discussed by Martens and Naes
(14) involves simultaneously the independent and dependent variables on the data com-
pression and decomposition operations. In spectrophotometry, the PLS calibration is done
by decomposition of both the concentration and absorbance matrix into latent variables:
A = T PT + E and C = U QT + F (8–9)







The scores and loadings are given by:

















The matrix and vector of the residuals in absorbances and concentration were found
by:
A1 = A – t P1 1
T and C1 = C – t q1 1
T (14–15)
From the general linear equation, the regression co-efficient was calculated by:
b = W(PT W)–1q (16)
where W is a weight matrix. Using the linear regression, the constant a is calculated by
a = Cmean – ATmean ´ b (17)
Like in the PCR method, the PLS calibration is used for the estimation of compo-
unds in the samples (12).
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RESULTS AND DISCUSSION
Calibration matrix and selection of spectral zones for analysis by ILS, PCR and PLS-1
Fig. 1. shows the overlain zero-order spectra for RA, AS and AT ternary mixture in
methanol. As shown, RA, AS and AT exhibit absorption maxima at 206, 226 and 246 nm,
respectively. The RA, AS and AT spectra are overlapped in the absorption maxima. For
this reason, three chemometric calibrations, using the zero-order spectra, were separa-
tely applied to simultaneous determination of these drugs in mixtures. The absorbance
matrix was obtained by measuring the zero-order absorbance in the wavelength range
between 210 and 320 nm, as shown. The quality of multicomponent analysis is depend-
ent on the wavelength range and the spectral mode used. PLS and PCR procedures are
designated to be full spectrum computational procedures; hence wavelength selection is
seemingly unnecessary, and so all available wavelengths are often used. However, mea-
surements from spectral wavelengths that are non-informative in a model degrade per-
formance. Original and reconstructed spectra of the calibration matrix were compared in
order to select the range of wavelengths along with using the root mean squared error of
calibration (RMSEC), root mean squared error of cross validation (RMSECV) and root
mean squared error of prediction (RMSEP) values. Besides, the regions where recon-
struction of the spectrum gives the best results were also considered. The wavelength
range 220–320 nm with 1-nm intervals was selected, since this range was providing the
greatest amount of information about the three components.
Training and validation set design
A training set design of the concentration data corresponding to RA, AS and AT
mixtures was organized statistically to maximize the information content in the spectra
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Fig. 1. Overlain spectra of ramipril, acetylsalicylic acid and atorvastatin calcium.
and to minimize the error of multivariate calibrations, as shown in Table I. The training
set of 25 standard mixture solutions containing concentrations with different ratios of
RA, AS and AT was prepared in the linearity range of three drugs; it is shown in Table I.
To validate the developed methods, a prediction (validation) set was prepared as shown
in Table II.
ILS method
In the calibration equation, the coefficient matrix (P) was obtained from the linear
equation system using the absorbance corresponding to the training set. Introducing P
into the equation system gives the ILS calibrations. Absorbance values of the samples, at
the selected wavelengths in the spectral region from 210 to 320 nm, were introduced into
the obtained calibrations and the quantities of RA, AS and AT in the synthetic mixture
prediction (validation) set and capsules were predicted.
PCR method
The PCR calibration was constructed using the PCR algorithm as explained earlier.
The zero-order absorbances measured at selected wavelength ranges were used for cali-
bration; they were introduced in the PCR calibrations. The quantity of each drug in the
synthetic mixture prediction (validation) set and capsules were determined.
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Table III. Statistical data for the prediction set by PLS 1, PCR and ILS methods
Parameter
PLS-1 PCR ILS
RA AS AT RA AS AT RA AS AT
Wavelength
range (nm)a
207–312 207–312 220–300 207–312 207–312 220–300 207–312 207–312 220–300
Linear range
(µg mL–1)
1–5 10–50 2–10 1–5 10–50 2–10 1–5 10–50 2–10
RMSEC 0.047 0.494 0.190 0.047 0.177 0.190 0.040 0.321 0.124
RMSEP 0.045 0.491 0.219 0.045 0.229 0.221 0.040 0.421 0.125
Mean (%) 100.00 100.20 99.79 100.10 99.84 99.89 99.65 99.95 99.71
RSD (%) 1.55 1.87 3.26 1.55 1.05 3.26 1.44 2.150 2.320
Rb 0.999 1.000 0.995 0.999 1.000 0.995 1.005 1.000 0.999
Slopeb 0.003 0.000 0.027 0.003 0.005 0.027 –0.025 0.048 –0.014
Interceptb 0.999 0.999 0.998 0.999 1.000 0.998 1.000 1.000 0.999
RA – ramipril, AS – acetylsalicylic acid, AT – atorvastatin calcium
a Selection by trial and error method based on RMSECV and RMSEC.
b Calculated for actual and predicted values of the prediction set.
PLS-1 method
The corresponding calibration was obtained by using PLS algorithms, as explained
earlier. The zero-order absorbance was measured in the same range and on the same
sample as in the PCR method.
Statistical analysis in selecting the number of principal components or factors
We can define the ability of a calibration in several ways. In this subsection, we calcu-
lated the standard variation of chemometric calibrations in the case of investigated mix-
tures. An appropriate choice of the number of principal components or factors is neces-
sary for PCR and PLS-1 calibrations. The number of factors should account as much as
possible for the experimental data without resulting in overfitting. Various criteria have
been developed to select the optimum number (13, 14). A cross-validation method leaving
out one sample at a time was employed (15). With a calibration set of 25 calibration spec-
tra, PLS-1 and PCR calibrations on 24 calibration spectra were performed, and using this
calibration the concentration of the sample left out during the calibration process was
determined. This process was repeated 25 times until each calibration sample had been
left once. The predicted concentrations were compared with the known concentrations
of the compounds in each calibration sample. The method developed by Haaland and
Thomas (16) was used for selecting the optimum number of factors, which involves se-
lecting that model including the smallest number of factors that result in an insignificant
difference between the corresponding RMSECV and the minimum RMSECV. To validate
the model, both RMSECV and RMSEP were considered; they must be as low as possible
for a particular model. RMSEP were calculated for each method as follows:
RMSECV = S













where Cact and Yact and Cpred and Ypred denote actual and determined concentrations of
the calibration and prediction set samples, respectively. Ic and Ip are the total number of
calibration and prediction set samples, respectively. The numerical values of RMSEC
and RMSEP are given in Tables III and VI. By inspection we conclude that RMSEC is
minimal for PLS and PCR methods for all the three drugs. RMSEP values of the same
mixtures are displayed in Table III and similar behavior of the values was observed as
for RMSEC. The mean recoveries and the relative standard deviations of the proposed
methods were computed (Tables IV and V).
Figures of merit
Determination of figures of merit (FOM) is necessary for the validation of
chemometric methods. FOM, such as sensitivity (SEN), selectivity (SEL), the inverse of
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analytical sensitivity (ã–1), limit of detection (LOD) and limit of quantification (LOQ) can
be estimated and used to compare analytical methods. Sensitivity here refers to the cali-
bration sensitivity, as it is calculated from the calibration set. It differs from analytical
sensitivity, g, the inverse of which is useful in comparing two different methods regard-
less of the calculation steps. When expressing FOM for multivariate calibration meth-
ods, the part of the signal that referes to the analyte is more important than the total sig-
nal. This unique signal is termed net analyte signal (NAS) and is defined as the part of
the signal that is orthogonal to the signal of the interferences (other analytes) present in
the sample (17). The NAS is a vector containing the values for each sample and can be
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Table V. Recovery from commercial preparations by the standard addition method by PLS 1, PCR and
ILS methods
Drug










R1 RA 99.9 1.1 99.8 1.2 99.3 1.2
AS 100.0 0.6 99.9 0.6 100.4 0.8
AT 99.8 0.4 99.7 0.4 100.4 2.2
R2 RA 100.4 1.3 100.3 1.3 100.1 1.0
AS 99.9 0.3 99.8 0.3 100.0 0.3
AT 99.6 0.8 99.5 0.8 98.0 4.3
R3 RA 100.0 0.2 99.9 0.2 99.9 1.3
AS 99.9 0.7 99.8 0.7 100.3 0.8
AT 99.9 0.7 99.8 0.7 100.6 1.2
a Mean for six determinations.
RA – ramipril, AS – acetylsalicylic acid, AT – atorvastatin calcium.
R1, R2, R3 – Recovery done by the standard addition method at three levels.
Table IV. Composition and results for the commercial formulation set by PLS1, PCR and ILS methods
Concentration
(µg mL–1)
Label claim found (%)a
PLS-1 PCR ILS
RA AS AT RA AS AT RA AS AT RA AS AT
F 2 30 4 99.8 99.0 99.8 98.5 98.7 98.5 97.4 98.0 97.5
R1 3 40 6 100.1 100.9 99.5 98.8 98.5 98.2 97.2 98.3 98.3
R2 4 45 8 100.0 101.1 100.8 98.7 98.3 99.5 99.7 97.9 96.0
R3 5 50 10 100.7 98.8 100.0 99.4 99.4 98.7 95.4 99.3 98.5
a Mean of six determinations.
F – Commercial formulation.
R1, R2, R3 – Recovery done by the standard addition method at three levels.
related to the regression vector, b, from any multivariate calibration model, such as






where the symbol means the Euclidian norm, which is defined as the square root of
the squared elements of a vector. Other FOMs can be subsequently calculated as func-
tions of the NAS (or the regression vector). The SEL is a measure, ranging from 0 to 1, of
how unique the spectrum of the analyte is compared to the other species. It indicates the
part of the total signal that is not lost due to spectral overlap, and can be defined in the













means the Euclidian norm of a vector, NAS is the net analyte sig-
nal of the corresponding analyte and X is the total signal of the sample. A more informa-
tive FOM is analytical sensitivity (g), which is defined, in analogy with univariate cali-





where e is a measure of the instrumental noise. The value of e may be estimated from
the standard deviation of the spectral residuals of that particular multivariate calibration
model, while 0.001 was used for the ILS method. With the inverse of g (g-1) (18), it is pos-
sible to establish a minimum concentration difference that is discernible by the analyti-
cal method in the absence of experimental error. Concerning the limits of detection and
quantification, the following simple equations have been proposed for their estimation:
LOD = 3.3 b e and (23)
LOQ = 10 b e (24)
where b is the regression coefficient of the selected component and g is the standard de-
viation of the errors in the spectra of the calibration model, while for the ILS model, a
value equivalent to 0.001 is used as error (19).
Capsule analysis
Twenty capsules were weighed accurately and emptied into a mortar. An amount
equivalent to one capsule was dissolved in methanol by sonication. The solution was fil-
tered into a 100-mL calibrated flask through Whatman no. 42 filter paper and diluted to
an appropriate volume with the same solvent. The proposed techniques were applied to
the analysis of the capsule formulation, and in this case, the mean percent and standard
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deviation of the label claim amount found in PLS 1, PCR and ILS methods for the com-
mercial formulation were as follows for RA 99.7 ± 0.8, 99.6 ± 0.8 and 99.5 ± 1.4, for AS
99.7 ± 0.4, 99.6 ± 0.4 and 101.1 ± 2.0 and for AT 100.0 ± 1.1, 99.9 ± 1.1 and 99.6 ± 2.4, re-
spectively. The results of all methods were very close to each other.
Standard addition method for validation (recovery studies)
The interference of excipients and additives for three drugs was tested by the appli-
cation of the proposed methods to a commercial capsule formulation and no interfer-
ence was observed according to the experimental results performed as follows. Standard
solutions of pure drugs corresponding to capsule content were added to the solutions
and analyzed by the PLS 1, PCR and ILS methods. In this case, the mean and standard
deviation of PLS 1, PCR and ILS models was found by the standard addition method
and is shown in Table VI. It can be seen from the LOD, LOQ and analytical sensitivity (Ta-
ble VI) that PLS 1 and PCR methods do not differ significantly. From the recovery results
for each drug, it was found that no interference by the excipients was observed (Table V).
CONCLUSIONS
Three chemometric methods were applied successfully to simultaneous determina-
tion of RA, AS and AT in laboratory mixtures and pharmaceutical capsules. Model that
gave lowest RMSEC values when used for predicting the unknown samples, predicted
well by giving lowest RMSEP values. On the other hand, the fundamental advantages of
our investigated methods are the simultaneous analysis of the mixture of the subject
drugs, without chemical pretreatment, speed of analysis and cost effectiveness. Finally,
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Table VI. Figures of merit for PLS 1, PCR and ILS methods
Parameter
Ramipril Acetylsalicylic acid Atorvastatin calcium
PLS 1 PCR ILS PLS 1 PCR ILS PLS 1 PCR ILS
Factors 4 4 – 4 4 – 5 5 –
RMSEC 0.0471 0.0472 1.823´10–13 0.1766 0.1766 5.307´10–12 0.1232 0.1265 1.207´10–12
RMSECV 0.0591 0.0592 0.0353 0.2323 0.2323 0.2595 0.1710 0.1751 0.1236
RMSEP 0.0443 0.0447 0.0401 0.2226 0.2292 0.2928 0.1253 0.1278 0.1250
SEN
(mL µg–1)
0.1633 0.1633 0.0064 0.1713 0.1713 0.0007 0.0209 0.0216 0.0025
SEL 0.0200 0.0201 0.0003 0.0688 0.0800 0.0003 0.0018 0.0018 0.0002
LOD
(µg mL–1)
0.2884 0.2884 0.4688 0.268 0.268 4.4008 0.4619 0.3889 1.2000
LOQ
(µg mL–1)
0.9614 0.9614 1.5625 0.8932 0.8932 14.6692 1.3397 1.2963 4.0000
ã¯1
(µg mL–1)
10.401 10.401 6.4000 11.196 11.196 0.6817 7.4643 7.7143 2.5000
SEN – calibration sensitivity; SEL – selectivity, LOD – limit of detection, LOQ – limit of quantitation, ã–1 – ana-
lytical sensitivity
all the developed methods can be applied to the routine analysis, quality control of mix-
tures and commercial preparations containing these three drugs.
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S A @ E T A K
Simultano UV-spektrofotometrijsko odre|ivanje ramiprila, acetilsalicilne kiseline i
atorvastatin kalcija u kapsulama primjenom kemometrijskih metoda
A. S. KAMATCHI SANKAR, THANGARASU VETRICHELVAN i DEVASHYA VENKAPPAYA
U radu su opisane tri razli~ite spektrofotometrijske metode za odre|ivanje ramipri-
la, acetilsalicilne kiseline i atorvastatin kalcija u sirovinama i formulacijama. Preklapanje
podataka kvantitativno je rije{eno pomo}u kemometrijskih metoda, tj. metodama inver-
znih najmanjih kvadrata (ILS), regresije glavnog sastojka (PCR) i djelomi~nih najmanjih
kvadrata (PLS). Kalibracije su postavljene pomo}u matrice podataka za apsorpciju koja
odgovara matrici pripadaju}ih koncentracija. Podru~je linearnosti za ramipril iznosilo je
1–5, za acetilsalicilnu kiselinu 10–50, a za atorvastatin kalcij 2–10 mg mL–1. Matrica s ap-
sorbancijama dobivena je mjerenjem apsorbancije nultog reda na valnim duljinama iz-
me|u 210 i 320 nm. Set podataka za koncentracije ramiprila, acetilsalicilne kiseline i ator-
vastatin kalcija u smjesi statisti~ki je tako organiziran da osigura maksimalnu koli~inu
informacije u spektrima i minimalizira gre{ku multivarijantnih kalibracija. Primjenom
odgovaraju}ih algoritama za PLS, PCR i ILS na snimljene spektre kalibracijskog seta do-
biven je dobar model, koji je odabran na temelju RMSECV i RMSEP vrijednosti. Isti mo-
del je primijenjen i na set s predvi|enim vrijednostima i na kapsule sa smjesom ove tri
ljekovite tvari. Odre|ena je srednja vrijednost povrata za komercijalnu formulaciju te osta-
le analiti~ke izvedbene zna~ajke (kalibracijska osjetljivost, selektivnost, granica dokazi-
vanja, granica odre|ivanja i analiti~ka osjetljivost). Potvr|ena je primjenjljivost predlo-
`enih metoda u analizama lijekova u fizi~kim smjesama i u gotovim ljekovitim oblicima.
Klju~ne rije~i: izvedbene zna~ajke, multivarijantna kalibracija, ramipril, acetilsalicilna kiselina, ator-
vastatin kalcij
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